Production (Stage)
Zepp Health Corporation
ZEPP
$2.55
$0.000.00%
NYSE
| 12/31/2024 | 12/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 40.22% | -0.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 40.22% | -0.09% | |||
| Cost of Revenue | 49.15% | -1.36% | |||
| Gross Profit | 27.17% | 2.40% | |||
| SG&A Expenses | 4.67% | 4.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 24.51% | 0.84% | |||
| Operating Income | 28.71% | -50.63% | |||
| Income Before Tax | -75.93% | 261.11% | |||
| Income Tax Expenses | -- | 4,132.93% | |||
| Earnings from Continuing Operations | -178.31% | -400.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 212.50% | -155.64% | |||
| Net Income | -178.29% | -384.32% | |||
| EBIT | 28.71% | -50.63% | |||
| EBITDA | 27.49% | -25.45% | |||
| EPS Basic | -179.57% | -386.67% | |||
| Normalized Basic EPS | 1.27% | 344.87% | |||
| EPS Diluted | -179.57% | -450.23% | |||
| Normalized Diluted EPS | 1.27% | 368.92% | |||
| Average Basic Shares Outstanding | -0.45% | -0.67% | |||
| Average Diluted Shares Outstanding | -0.46% | -5.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||